Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E0302 (mecobalamin) in Amyotrophic Lateral Sclerosis (ALS)
NCT00444613Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2007
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in amyotrophic lateral sclerosis (ALS), sponsored by Eisai Co., Ltd.. Started Apr 2007; status: completed.
02
Drugs
mecobalamin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00444613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444613.